Navigation Links
Ottawa researchers key to new neuromuscular disease care and research network
Date:6/13/2014

OTTAWA, June 12, 2014 The University of Calgary's Hotchkiss Brain Institute (HBI), the Canadian Institutes of Health Research (CIHR) and Muscular Dystrophy Canada have announced the launch of the Canadian Neuromuscular Disease Network. Four co-principal investigators in this national network are Ottawa-based: Dr. Bernard Jasmin, Dr. Rashmi Kothary, Dr. Jodi Warman and Dr. Hugh McMillan.

"The network is a critical initiative that will organize the efforts to improve clinical care and advance research in neuromuscular disease with expertise from around the country," says Dr. Bernard Jasmin, vice-dean research at the University of Ottawa Faculty of Medicine. "That almost half of the team's principal investigators are from Ottawa is a testament to the strength in neuromuscular research and neurosciences in this region."

Dr. Jasmin and Dr. Rashmi Kothary, deputy scientific director of the Ottawa Hospital Research Institute, are basic science researchers. Dr. Jodi Warman, a neurologist at the Ottawa Hospital and a neurogeneticist at the Children's Hospital of Eastern Ontario (CHEO), and Dr. Hugh McMillan, a child neurologist at CHEO, are both clinicians who carry out translational research and clinical trials.

The new network hopes to empower patients and families through improved access to needed information and resources, along with a patient portal to connect with each other. In addition, the network plans to enhance the delivery of clinical care, increase capacity and collaboration, and improve training opportunities for researchers and clinical care providers.

Neuromuscular diseases as a group include over 150 different conditions, including muscular dystrophies, multiple sclerosis, spinal muscular atrophy and amyotrophic lateral sclerosis (commonly known as Lou Gehrig's disease). These diseases result in weakness and physical disability due to damage to muscle and nerve tissue.

"While neuromuscular diseases are
'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Don’t Compromise Your Health, Ottawa Residents!
2. TEAL Ottawa Launches Skin Imperfection Treatments by Thermo LO
3. Paul McCartney Tickets: Paul McCartney Tickets in Kanata Ottawa at the Scotiabank Place Go on Sale on Friday, April 26th at 10:00 a.m. Local Time
4. Ottawa researcher named 2013 Champion of Genetics
5. Champion of Genetics funding to Ottawa researcher
6. 2013 Ottawa Consumer Choice Award Winners
7. The Royal Mental Health Center of Ottawa Releases a Complete Mobile Application Suite for Veterans Coping with Operational Stress Injuries
8. Heritage Woods of Ottawa Affordable Assisted Living to Host Craft and Bake Sale
9. Alcohol & Drug Rehab Ottawa Launches Program Aimed at Reducing Adolescent Marijuana Addiction
10. Ottawa researchers find new pathway connected to type 2 diabetes
11. Ottawa researcher receives international award for obesity research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Reinberg HealthDay Reporter WEDNESDAY, ... cancer cells grow may help doctors diagnose and treat the ... investigators have found that the deadliest skin cancers occur most ... a long history of sun exposure. These lesions also ... Rapid cell growth -- called "high mitotic rate" -- ...
(Date:8/20/2014)... common approach to treating kidney failure by removing waste ... for people who suddenly developed the condition, in an ... School of Medicine. , Their findings, published online in ... an aggressive method that is standardly used for people ... benefit to the patient. , "Our findings question the ...
(Date:8/20/2014)... NEW YORK, NY (August 20, 2014) Research from ... a critical role in stomach cancer growth and that ... be an effective treatment for the disease. The study ... MD, in collaboration with Duan Chen, MD, PhD, in ... Science Translational Medicine . , "Scientists have long observed ...
(Date:8/20/2014)... 20, 2014 The non-small cell lung ... in the offing across the top 8 developed nations, ... to around USD 8 billion by 2020-end, posting a ... is projected to be driven by innovative therapies entering ... lacking efficient treatment, unlike the non-squamous segment. Thus, patients ...
(Date:8/20/2014)... CA (PRWEB) August 20, 2014 The main ... 12 per diode panel band perfect spectrum that encompasses the ... most likely to use during photosynthesis. A key point ... is that they almost exclusively reside between 440-480 on the ... the red side of the spectrum. The KIND LED K3 ...
Breaking Medicine News(10 mins):Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Pitt analysis questions use of acute hemodialysis treatment 2Health News:Severing nerves may shrink stomach cancers: Botox injections slow growth of tumors in mice 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 2Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 3Health News:Top 8 Developed Nations NSCLC Market to Grow at CAGR of 6.6% Through 2020, Says GBI Research in Its Report Published at MarketPublishers.com 4Health News:Cheap LED Grow Lights Are Quickly Being Replaced by Premium Grow Lights 2
... to cover the American Stroke Associations International Stroke Conference ... Ernest N. Morial Convention Center in New Orleans, La. ... world of medical scientists and physicians engaged in research ... death in the United States. Nearly 4,000 attendees ...
... 20, 2008 New data revealing decreasing trends in cancer ... cancer deaths in particular, highlight the remarkable benefits of ... these tests is unrealized for many Americans according to ... Racial minorities, uninsured Americans and even Medicare patients who ...
... Feb. 19 The Ensign,Group, Inc. (Nasdaq: ... the Ensign(TM) group of,skilled nursing, rehabilitative care ... Waverly Park skilled nursing facility in,Tucson, Arizona ... Facility,Program established by the Centers for Medicare ...
... November 5, 2007, under increasing,government pressure, Bayer Pharmaceuticals Corporation ... Trasylol after a Canadian clinical study,found the drug could ... other drugs.,The Food and Drug Administration asked the company ... during heart bypass surgery,pending detailed review of preliminary results ...
... findings show that a specialized virus with the ability to ... brains of mice and eliminate them. Healthy brain tissue remained ... The Journal of Neuroscience . With more research, the technique ... cancer in humans. , Most importantly, this study finds that ...
... Accenx Technologies, Inc., a,leading company in electronic ... solutions, announced today the launch of their,new Physician,s ... their,clients, such as large health systems, hospitals, and ... outreach programs, and connect,physician practices to RyTRAK HIE ...
Cached Medicine News:Health News:US cancer deaths down but far too few Americans screened for colon cancer 2Health News:US cancer deaths down but far too few Americans screened for colon cancer 3Health News:The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 2Health News:The Ensign Group Successfully Graduates Troubled Nursing Home from CMS Special Focus Facility Program 3Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 2Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 3Health News:Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes' 4Health News:Tumor-killing virus selectively targets diseased brain cells 2Health News:New Accenx Physician's Relations Department! Now At Your Service 2
(Date:8/20/2014)... NEW YORK, Aug 20, 2014 Reportlinker.com ... available in its catalogue: Global Patient ... This report analyzes the worldwide markets ... following Product Segments: Floor Scales, Infant & Baby ... report provides separate comprehensive analytics for the US, ...
(Date:8/19/2014)... 2014   Lincor Inc. today announced ... to New Jersey -based healthcare ... Health will deploy Lincor,s PatientLINC technology across its ... and Hoboken University Medical Center. Lincor,s ... solutions to help hospitals reach new levels of ...
(Date:8/19/2014)... , Aug. 19, 2014 /PRNewswire-iReach/ -- ChemImage founder ... present a scientific poster describing an innovative diagnostic procedure ... 2014: Shedding New Light on Disease (SPEC) conference in ... Dr. Treado,s poster entitled, "Development of in vitro Diagnostics ... will be discussed during the conference poster session on ...
Breaking Medicine Technology:Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Lincor Announces Agreement With CarePoint Health For State-Of-The-Art Patient Engagement Technology 2ChemImage Scientists Present Latest Developments for in vitro Detection of Colorectal Cancer Using Raman Molecular Imaging (RMI) at International Conference Focused on Biomedical Applications of Raman Spectroscopy 2
... Claron Technology makes the PROFIT 200 list for ... developer Claron Technology, headquartered in Toronto, has been included ... Fastest-Growing Companies by PROFIT Magazine. Ranking Canada,s Fastest-Growing Companies ... country,s most successful growth companies. Published in the Summer ...
... a medical technology company developing a platform of endoscopically ... obesity and type 2 diabetes, announced today the completion ... led by Broadline Capital, a global private equity investment ... issued and pending patents, will use the funding to ...
Cached Medicine Technology:Claron Technology Makes the PROFIT 200 List for the Third Consecutive Year 2EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital 2
... UltraClean Agarose, Molecular Biology Grade, ... separation of nucleic acids. It ... DNA fragments from 0.2 to ... UltraClean Agarose is tested and ...
Inquire...
... Agarose 1000 is specifically formulated for high ... fragments <1000 bp. This standard melting temperature ... little as 10 bp difference in size. ... strong gel structure for better handling and ...
High EEO (-mr) (0.23-0.26), suitable for IEP, Gel point (1.5%): 36 1.5 °C Gel strength (1%): > 750 g/cm2....
Medicine Products: